Eilish McCann

Statistics

Publications

Citations

975

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Becton Dickinson (United States)

Amsterdam University Medical Centers

Children's Hospital of Philadelphia

Regeneron (United States)

Eilish McCann is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, carbapenem resistance, and infectious diseases.

ORCID

Publications per year

2009–2024

Publications

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 456 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study

Eilish McCann, Arjun Srinivasan, C Andrew DeRyke et al. · Open Forum Infectious Diseases · 2018 · 110 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age

Mirna Chehade, Evan S. Dellon, Jonathan M. Spergel et al. · New England Journal of Medicine · 2024 · 110 citations

Life Sciences, Pharmacology, Pharmacotherapy +14

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins et al. · The Lancet. Gastroenterology & hepatology · 2023 · 102 citations · Full text

Medicine, Pharmacotherapy, Adolescent Medicine +7

Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections

Ying P. Tabak, Anita Sung, G. Ye et al. · Journal of Hospital Infection · 2018 · 45 citations · Full text

Life Sciences, Infectious Diseases, Pharmacoeconomics +16

1–5 of 13